248 related articles for article (PubMed ID: 8733870)
21. The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden).
Simioni P; Prandoni P; Lensing AW; Scudeller A; Sardella C; Prins MH; Villalta S; Dazzi F; Girolami A
N Engl J Med; 1997 Feb; 336(6):399-403. PubMed ID: 9010145
[TBL] [Abstract][Full Text] [Related]
22. ARMS test for diagnosis of factor VLeiden mutation, a common cause of inherited thrombotic tendency.
Yandava CN; Zappulla DC; Korf BR; Neufeld EJ
J Clin Lab Anal; 1996; 10(6):414-7. PubMed ID: 8951612
[TBL] [Abstract][Full Text] [Related]
23. Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty.
Svensson PJ; Benoni G; Fredin H; Björgell O; Nilsson P; Hedlund U; Nylander G; Bergqvist D; Dahlbäck B
Thromb Haemost; 1997 Sep; 78(3):993-6. PubMed ID: 9308742
[TBL] [Abstract][Full Text] [Related]
24. Thrombophilia in childhood: to test or not to test.
Heleen van Ommen C; Middeldorp S
Semin Thromb Hemost; 2011 Oct; 37(7):794-801. PubMed ID: 22187402
[TBL] [Abstract][Full Text] [Related]
25. Inherited resistance to activated protein C, a major basis of venous thrombosis, is caused by deficient anticoagulant cofactor function of factor V.
Dahlbäck B
Haematologica; 1995; 80(2 Suppl):102-13. PubMed ID: 7628762
[No Abstract] [Full Text] [Related]
26. Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease.
Zöller B; He X; Dahlbäck B
Thromb Haemost; 1995 May; 73(5):743-5. PubMed ID: 7482396
[TBL] [Abstract][Full Text] [Related]
27. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
[TBL] [Abstract][Full Text] [Related]
28. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives.
Hellgren M; Svensson PJ; Dahlbäck B
Am J Obstet Gynecol; 1995 Jul; 173(1):210-3. PubMed ID: 7631684
[TBL] [Abstract][Full Text] [Related]
29. Resistance to activated protein C, the FV:Q506 allele, and venous thrombosis.
Dahlbäck B; Hillarp A; Rosen S; Zöller B
Ann Hematol; 1996 Apr; 72(4):166-76. PubMed ID: 8624369
[TBL] [Abstract][Full Text] [Related]
30. Resistance to activated protein C: a major cause of inherited thrombophilia.
Jensen R; Ens GE
Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
[TBL] [Abstract][Full Text] [Related]
31. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
[TBL] [Abstract][Full Text] [Related]
32. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
[TBL] [Abstract][Full Text] [Related]
33. Thrombophilias and recurrent pregnancy loss.
Kutteh WH; Triplett DA
Semin Reprod Med; 2006 Feb; 24(1):54-66. PubMed ID: 16418978
[TBL] [Abstract][Full Text] [Related]
34. [Familial thrombophilia due to resistance to activated protein C].
Cuevas V; Tortosa JI; Rodríguez C; Alonso JM; García Frade LJ
Sangre (Barc); 1994 Aug; 39(4):283-6. PubMed ID: 7985058
[TBL] [Abstract][Full Text] [Related]
35. Ischaemic stroke in infancy and childhood: role of the Arg506 to Gln mutation in the factor V gene.
Nowak-Göttl U; Sträter R; Dübbers A; Oleszuk-Raschke K; Vielhaber H
Blood Coagul Fibrinolysis; 1996 Oct; 7(7):684-8. PubMed ID: 8958390
[TBL] [Abstract][Full Text] [Related]
36. The Leiden Thrombophilia Study (LETS).
van der Meer FJ; Koster T; Vandenbroucke JP; Briët E; Rosendaal FR
Thromb Haemost; 1997 Jul; 78(1):631-5. PubMed ID: 9198229
[No Abstract] [Full Text] [Related]
37. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
Dahlbck B
J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
[TBL] [Abstract][Full Text] [Related]
38. Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation.
Manten B; Westendorp RG; Koster T; Reitsma PH; Rosendaal FR
Thromb Haemost; 1996 Oct; 76(4):510-3. PubMed ID: 8902987
[TBL] [Abstract][Full Text] [Related]
39. Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency.
Zöller B; Holm J; Svensson P; Dahlbäck B
Thromb Haemost; 1996 Feb; 75(2):270-4. PubMed ID: 8815575
[TBL] [Abstract][Full Text] [Related]
40. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
Dahlbäck B
Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
